September/October 2018

View All Issues

Editor's Note

When I first heard about the growing research on the therapeutic use of psychedelics to treat trauma, I was frankly a bit bemused. But it’s been hard to dismiss the overwhelmingly positive results of early trials. Will psychedelic-assisted therapy continue to gain traction? Will it eventually be practice-changing for everyday clinicians? We can’t know the answer at this point, but what's clear is that the clinical interest in psychedelics is much more than a haphazard, tie-dyed pursuit.

Read More






Extra Feature